does glp-1 lower testosterone in women The dual impact of receptor agonists on metabolic and reproductive health polycystic ovary syndrome: insights from human and animal trials Men and Women May Respond

We aimed to examine the association of glucagon-like peptidase 1 receptor agonist (GLP-1a), when compared with other glucose-lowering drugs (oGLD), with liver and non-liver complications in patients with diabetic MASLD

Among patients with PMOS and related metabolic conditions such as obesity, these therapies may be prescribed for labeled metabolic indications while still shaping the broader PMOS care pathway

Factors such as diabetes, obesity, fertility history, previous pregnancy complications, and overall health can all influence the best path forward

There are GLP-1 prescription websites that connect you with a prescribing doctor

Unlike stimulant-based weight loss medications, GLP-1 and dual GIP/GLP-1 agonists do not function primarily as metabolic stimulants or thermogenic agents